🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-10-01
Trial ID
NCT05900401
Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-05
Trial ID
NCT00869999
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-03
Trial ID
NCT00031980
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Status
Terminated
Location
Cancer Institute of New Jersey at Hamilton
Start Date
2008-06-16
Trial ID
NCT00728845
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and melpha...
Status
Terminated
Location
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Start Date
2005-07
Trial ID
NCT00121186
Giving chemotherapy drugs, such as fludarabine and busulfan, before a donor...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2007-06
Trial ID
NCT00619645